Drawing for RYSANSO

USPTO serial 50165282

RYSANSO

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with RYSANSO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karen K. Won

Karen K. Won Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.One Financial CenterBoston, MA 02111United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, prescription psychotropics; Psychotropic preparations for the treatment of psychiatric and psychological diseases and disorders; Psychotherapeutic preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions affecting mood, thought, behavior, and perception; Pharmaceutical preparations for the treatment and management of psychiatric, psychological, and neurological disorders; Therapeutic agents for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury; Medicaments to help assist with treatment and management of psychiatric, psychological, and neurological disorders.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 16, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 16, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance